These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2532229)

  • 41. Comparison of ipratropium solution, fenoterol solution, and their combination administered by nebulizer and face mask to children with acute asthma.
    Watson WT; Becker AB; Simons FE
    J Allergy Clin Immunol; 1988 Dec; 82(6):1012-8. PubMed ID: 2974463
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of fenoterol, ipratropium bromide, and their combination in patients with asthma or chronic airflow obstruction.
    Huhti E; Poukkula A
    Respiration; 1986; 50 Suppl 2():298-301. PubMed ID: 2951825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined cholinergic antagonist and beta 2-adrenoceptor agonist bronchodilator therapy by inhalation.
    Marlin GE; Berend N; Harrison AC
    Aust N Z J Med; 1979 Oct; 9(5):511-4. PubMed ID: 161170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solution assessing dose-response and duration of action.
    McIntosh D
    Respiration; 1986; 50 Suppl 2():310-2. PubMed ID: 2951827
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Effect of fenoterol, ipratropium bromide and combination drug-berodual-on selected clinical parameters and lung function in patients with asthma].
    Rutkowski R; Kazberuk M; Siergiejko Z; Chyrek-Borowska S
    Pneumonol Alergol Pol; 1994; 62(7-8):358-64. PubMed ID: 7951083
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ipratropium bromide (Atrovent) in childhood asthma: a cumulative dose-response study.
    Friberg S; Graff-Lonnevig V
    Ann Allergy; 1989 Feb; 62(2):131-4. PubMed ID: 2521989
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room.
    Rebuck AS; Chapman KR; Abboud R; Pare PD; Kreisman H; Wolkove N; Vickerson F
    Am J Med; 1987 Jan; 82(1):59-64. PubMed ID: 2879458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical study on bronchodilation induced by a metered aerosol of fenoterol in combination with ipratropium bromide.
    Bisetti A; Guerzoni P; Cavalieri C; Moretti M; Marchioni CF
    Respiration; 1986; 50 Suppl 2():160-4. PubMed ID: 2951797
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Combination aerosol for bronchial asthma in childhood].
    Klabuschnigg A; Horak F; Rottensteiner K; Weissenbacher G; Vogt R
    Padiatr Padol; 1983; 18(4):347-53. PubMed ID: 6227862
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controlled clinical study of a long-term treatment of chronic obstructive lung disease using a combination of fenoterol and ipratropium bromide in aerosol form.
    Serra C; Giacopelli A
    Respiration; 1986; 50 Suppl 2():249-53. PubMed ID: 2951816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antitussive properties of inhaled bronchodilators on induced cough.
    Lowry R; Wood A; Johnson T; Higenbottam T
    Chest; 1988 Jun; 93(6):1186-9. PubMed ID: 2967164
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of Duovent in the prevention of exercise-induced asthma.
    Sanguinetti CM; De Luca S; Gasparini S; Massei V
    Respiration; 1986; 50 Suppl 2():181-5. PubMed ID: 2951802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Controlled clinical study of the effects of a single aerosol administration of a fenoterol-ipratropium bromide combination in comparison with salbutamol].
    Ginesu F; Ortu AR; Schena GP; Deiola G; Polo F
    Arch Monaldi; 1983; 38(5-6):241-54. PubMed ID: 6238579
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of ipratropium bromide and fenoterol aerosols in pulmonary emphysema.
    Hughes JA; Tobin MJ; Bellamy D; Hutchison DC
    Thorax; 1982 Sep; 37(9):667-70. PubMed ID: 6218647
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Failure of ipratropium bromide to modify the diurnal variation of asthma in asthmatic children.
    Sly PD; Landau LI; Olinsky A
    Thorax; 1987 May; 42(5):357-60. PubMed ID: 2958950
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bronchial responsiveness to hyperventilation in children with asthma: inhibition by ipratropium bromide.
    Wilson N; Dixon C; Silverman M
    Thorax; 1984 Aug; 39(8):588-93. PubMed ID: 6236576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of effects of inhaling a combined preparation of fenoterol with ipratropium bromide (Duovent) with those of fenoterol and salbutamol.
    Tang OT; Flatley M
    Postgrad Med J; 1984; 60 Suppl 1():24-7. PubMed ID: 6233547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salbutamol versus Duovent (a combination of fenoterol and ipratropium bromide) in asthma.
    Flint K; Hockley B; Johnson NM
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():548-50. PubMed ID: 6225674
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of bronchodilatation produced by an anticholinergic (ipratropium bromide), a beta-2 adrenergic (fenoterol) and their combination in patients with chronic obstructive airway disease. An open trial.
    Guleria R; Behera D; Jindal SK
    J Assoc Physicians India; 1991 Sep; 39(9):680-2. PubMed ID: 1839993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison between aerosol and powder delivery system of fenoterol plus ipratropium bromide ('Duovent') in patients with asthma and chronic bronchitis.
    Town GI
    Pharmatherapeutica; 1988; 5(4):246-8. PubMed ID: 2971977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.